Manufacturers of automated systems and the manufacturers of the components used in these systems have been allocating an enormous amount of time and effort in the past years developing and conducting research on automated systems. The effort spent has resulted in the availability of prototypes demonstrating new capabilities as well as the introduction of such systems to the market within different domains. Manufacturers of these systems need to make sure that the systems function in the intended way and according to specifications which is not a trivial task as system complexity rises dramatically the more integrated and interconnected these systems become with the addition of automated functionality and features to them. With rising complexity, unknown emerging properties of the system may come to the surface making it necessary to conduct thorough verification and validation (V&V) of these systems. VALU3S aims to design, implement and evaluate state-of-the-art V&V methods and tools in order to reduce the time and cost needed to verify and validate automated systems with respect to safety, cybersecurity and privacy (SCP) requirements. This will ensure that European manufacturers of automated systems remain competitive and that they remain world leaders. To this end, a multi-domain framework is designed and evaluated with the aim to create a clear structure around the components and elements needed to conduct V&V process through identification and classification of evaluation methods, tools, environments and concepts that are needed to verify and validate automated systems with respect to SCP requirements. The implemented V&V methods as well as improved process workflows and tools will also be evaluated in the project using a comprehensive set of demonstrators built from 13 use cases with specific SCP requirements from 6 domains of automotive, industrial robotics, agriculture, Aerospace, railway and health.

MindGAP presents a radical new vision that may BRIDGE the GAP between HEALTH status and MIND/BODY interactions and lead to a paradigm shift in medicine. The disruptive idea presented herein is sustained by relevant data presented in the literature: (i) exosomes circulate throughout the body as messengers of health and disease, transporting genetic data to be delivered into a recipient cell; (ii) and exosomes are implicated in brain activity, having the ability to cross the blood brain barrier. Thus, when exosomes circulate and exit the brain to peripheral cells, there is a message transported therein, which is related to its cargo inside the vesicle. Overall, we aim to know which cargo is related to health and which cargo is related to disease. Traditionally, everyone has been looking for disease indicators to detect disease. Herein, we look for sensitive health indicators that may change under disease installation, therefore yielding an unprecedented early disease detection possibility. Moreover, the possibility of using MINDFULNESS meditation as a mind-related tool to control the cargo of exosomes is explored herein. If meditation is successful in changing the behaviour and attitudes of many people, fighting depression, etc., it means that the exosomes cargo may be changed through this process. Thus, this could be a major route to a self-healing approach before disease begins. Finally, all this knowledge opens doors to an innovative device that may be used by everyone to understand his/her health status. Overall, MindGAP targets (i) the missing relation between the genetic data in EXOSOMES and health status; (ii) interfacing this link with MIND-related activities; (iii) and to create an INNOVATIVE and PORTABLE DEVICE that TRACKS EXOSOMES and ANALYSIS their relevant genetic data, thereby allowing each individual to correlate this information with their own HEALTH STATUS and the installation of a pro-active attitude of each one of us against disease.